3Donald JL et al.Survey of extend-spectrum β-lactmmases among Klebsiella pneumoniae isolate[J].Scand J Infect Dis,1996,:17-20.
4Brecher SM.The emergence of antibiotic resistant bacteria.全国临床细菌学学术研讨会讲义[R].,1998.9.
5Eltringham I J, Wilson S M, Drobnieski F A. Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis [J]. J Clin Microbiol, 1999,37 ( 11 ) :3528-3532.
6McNemy R, Kiepiela K S, Bishop P M, et al. Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampin and streptomycine [J]. Int J Tuberc Lung Dis,2000.4:1 - 7.
7McNerny R, Wilson S M, Sidhu A M, et al. Inactivation of mycobacteriophage D29 using ferrous ammonium sulphate as a tool for the detection of viable myeobacterium smegmatis and myeobacterium tuberculosis [J] .Res Microbiol, 1998,149:487-495.
8Watterson S A, Wilson S M, Yates M D, et al. Comparison of three molecular assays for detection of rifampin resistance in Mycobacterium tuberculosis[J]. J Clin Mierobiol, 1998, 36(7): 1969-1973.
9WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance, 1997. Anti-tuberculosis drug resistance in the world [R]. World Health Organization publication, WHO/TB/97,227.
10Wilson S M,AI Suwaidi Z, McNemy R,et al. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis [J]. Nat Med, 1997,3(4):465 -468.
